BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.01B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$175M |
| 4 |
Merck
MRK
|
+$138M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$949M |
| 2 |
Bank of America
BAC
|
+$275M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$208M |
| 4 |
Canadian National Railway
CNI
|
+$154M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.27% |
| 2 | Financials | 8.4% |
| 3 | Industrials | 5.97% |
| 4 | Consumer Discretionary | 5.96% |
| 5 | Healthcare | 5.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSLR
2976
DELISTED
VIVINT SOLAR, INC.
VSLR
| $20.9K | ﹤0.01% |
1,719
+1,252
| +268% | +$17.2K |
|
|
SZYM
2977
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $20.9K | ﹤0.01% |
6,661
+1,688
| +34% | +$5.79K |
|
|
PSIX
2978
Power Solutions International
PSIX
$947M
| $20.9K | ﹤0.01% |
387
+277
| +252% | +$16.3K |
|
2979
Akebia Therapeutics
AKBA
$241M
| $20.9K | ﹤0.01% |
2,028
+1,845
| +1,008% | +$15.7K |
|
|
SSE
2980
DELISTED
SEVENTY SEVEN ENERGY INC COM
SSE
| $20.9K | ﹤0.01% |
4,864
+4,041
| +491% | +$21.3K |
|
|
MTSN
2981
DELISTED
MATTSON TECHNOLOGY INC
MTSN
| $20.9K | ﹤0.01% |
+6,228
| New | +$22.9K |
|
|
GST
2982
DELISTED
Gastar Exploration Inc.
GST
| $20.9K | ﹤0.01% |
6,751
+5,083
| +305% | +$16.1K |
|
2983
Citizens & Northern Corp
CZNC
$466M
| $20.9K | ﹤0.01% |
1,015
+716
| +239% | +$14.4K |
|
|
CIVI
2984
DELISTED
Civitas Solutions, Inc.
CIVI
| $20.8K | ﹤0.01% |
974
+710
| +269% | +$14.7K |
|
2985
Franklin Covey
FC
$227M
| $20.8K | ﹤0.01% |
1,023
+770
| +304% | +$15K |
|
2986
Option Care Health
OPCH
$3.61B
| $20.7K | ﹤0.01% |
1,428
+1,021
| +251% | +$17.3K |
|
|
MODN
2987
DELISTED
MODEL N, INC.
MODN
| $20.7K | ﹤0.01% |
1,741
+1,299
| +294% | +$15.4K |
|
|
UNIS
2988
DELISTED
Unilife Corporation
UNIS
| $20.7K | ﹤0.01% |
963
+666
| +224% | +$20.2K |
|
2989
Cardiff Oncology
CRDF
$76.6M
| $20.6K | ﹤0.01% |
+28
| New | +$19.9K |
|
2990
OceanFirst Financial
OCFC
$1.88B
| $20.6K | ﹤0.01% |
1,106
+791
| +251% | +$13.7K |
|
|
SPNS
2991
DELISTED
Sapiens International
SPNS
| $20.6K | ﹤0.01% |
1,987
+1,434
| +259% | +$13K |
|
|
INWK
2992
DELISTED
InnerWorkings, Inc.
INWK
| $20.6K | ﹤0.01% |
3,089
+2,250
| +268% | +$14.7K |
|
|
AREX
2993
DELISTED
Approach Resources Inc.
AREX
| $20.6K | ﹤0.01% |
3,006
-618
| -17% | -$4.66K |
|
|
CDMO
2994
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $20.5K | ﹤0.01% |
2,238
+1,639
| +274% | +$15.8K |
|
|
KMG
2995
DELISTED
KMG Chemicals Inc
KMG
| $20.5K | ﹤0.01% |
805
+579
| +256% | +$17K |
|
2996
STRATTEC Security
STRT
$338M
| $20.5K | ﹤0.01% |
298
+218
| +273% | +$15.9K |
|
2997
FuelCell Energy
FCEL
$1.63B
| $20.4K | ﹤0.01% |
5
+3
| +150% | +$15.5K |
|
|
RTK
2998
DELISTED
Rentech, Inc.
RTK
| $20.4K | ﹤0.01% |
1,909
+1,198
| +168% | +$13.7K |
|
|
VVUS
2999
DELISTED
Vivus Inc
VVUS
| $20.4K | ﹤0.01% |
864
+656
| +315% | +$16.1K |
|
|
JIVE
3000
DELISTED
Jive Software, Inc.
JIVE
| $20.4K | ﹤0.01% |
3,882
+2,895
| +293% | +$16.1K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2015 Portfolio in Review
As of Q2 2015, BNP Paribas Financial Markets held 3,782 positions worth $35.8B, down 0.81% from $36.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets's Q2 2015 filing shows 210 new, 2,320 increased, 874 reduced and 237 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M. The largest sale was Apple, an estimated $949M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.
- BNP Paribas Financial Markets's largest Q2 2015 buy was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.01B increase.
- BNP Paribas Financial Markets's biggest Q2 2015 reduction was Apple, cutting an estimated $949M.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2015, selling an estimated $55.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $35.8B portfolio in Q2 2015.
- BNP Paribas Financial Markets opened 210 new positions and closed 237 in Q2 2015.
- BNP Paribas Financial Markets's portfolio value fell 0.81% quarter-over-quarter to $35.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.